Search

everythinglearnresearchcommunity

for

Search:↓

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Lasers are effective for some skin conditions but can cause side effects like scarring and pigment changes; careful selection is important, and botulinum toxin type A is successful in reducing sweat in palmar hyperhidrosis.

Understanding the scalp's five-layer structure is crucial for better surgical outcomes and fewer complications.

The document says that treating burns late focuses on improving function, appearance, and helping patients return to normal life, using both non-surgical and surgical methods.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Understanding the science of skin stretching is crucial for safe and effective hair replacement techniques.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Wound healing is a complex process involving different cells and stages, leading to scar tissue formation and strength increase over time.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Glycogen levels in mouse skin drop after injury but increase during healing, returning to normal within a month.

Platelet Rich Plasma (PRP) treatment effectively reduces hair fall and increases hair growth in patients with Androgenetic Alopecia (AGA), but it may cause pain.

Skin stem cells are crucial for maintaining and repairing the skin and hair, using a complex mix of signals to do so.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The nanofibers with two growth factors improved wound healing by supporting structure, preventing infection, and aiding tissue growth.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Wnt1/βcatenin signaling is crucial for heart repair after injury.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.